Certified by Founder Lodge
Syremis Therapeutics
- ND
START UP
1 Disclosed Funding Rounds $165,000,000
0 Participating Investments
-
Founded date
2025
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipel
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 19 ,2025 | Series A | $165,000,000 |
Bain Capital
Third Rock Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Datatruck | $12,000,000 | (Jan 29, 2026)
Scholé AI | $3,000,000 | (Jan 29, 2026)
Tenbin Labs | $7,000,000 | (Jan 29, 2026)
Adaptive6 | $28,000,000 | (Jan 29, 2026)
Vention | $110,000,000 | (Jan 29, 2026)
